Range
6.76 - 6.87
Vol / Avg.
1.9K/3.5K
Div / Yield
-
52 Wk
6.31 - 9.33
Mkt Cap
158M
Payout Ratio
-
Open
6.78
P/E
-
EPS
-1.59
Shares
23.3M
Outstanding
23.3M
Total Float
2.4M
Benzinga - Sep 22, 2021, 4:07PM
Benzinga - Aug 30, 2021, 7:32AM
Benzinga - Aug 16, 2021, 8:39AM
Benzinga - Jul 26, 2021, 8:02AM
Sector: Health Care.Industry: Pharmaceuticals
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-01-03
REV
Q4 2021Est.ActualSurprise
EPS-0.030-0.130 -0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Anebulo Pharmaceuticals Questions & Anwsers

Q

How do I buy Anebulo Pharmaceuticals (ANEB) stock?

A

You can purchase shares of Anebulo Pharmaceuticals (NASDAQ: ANEB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Anebulo Pharmaceuticals's (ANEB) competitors?

Q

What is the target price for Anebulo Pharmaceuticals (ANEB) stock?

A

The latest price target for Anebulo Pharmaceuticals (NASDAQ: ANEB) was reported by Benchmark on May 25, 2021. The analyst firm set a price target for 15.00 expecting ANEB to rise to within 12 months (a possible 121.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Anebulo Pharmaceuticals (ANEB)?

A

The stock price for Anebulo Pharmaceuticals (NASDAQ: ANEB) is $6.77 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Anebulo Pharmaceuticals (ANEB) pay a dividend?

A

There are no upcoming dividends for Anebulo Pharmaceuticals.

Q

When is Anebulo Pharmaceuticals (NASDAQ:ANEB) reporting earnings?

A

Anebulo Pharmaceuticals’s $Q1 earnings are confirmed for after-market on $January 3, 2022.

Q

Is Anebulo Pharmaceuticals (ANEB) going to split?

A

There is no upcoming split for Anebulo Pharmaceuticals.

Q

What sector and industry does Anebulo Pharmaceuticals (ANEB) operate in?

A

Anebulo Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.